Literature DB >> 21999412

The purported effects of alcohol on appetite and weight in lung cancer patients.

Aminah Jatoi1, Yingwei Qi, Jason A Wampfler, Allan J Busta, Ping Yang, Sumithra Mandrekar.   

Abstract

Loss of appetite and weight predict poor outcomes in patients with advanced cancer. Effective and affordable palliative strategies are lacking; but because an emerging non-cancer literature suggests that alcohol can increase appetite and weight, this study explored associations between alcohol and clinical outcomes in lung cancer patients. Among 404 consecutive lung cancer patients enrolled in the Mayo Clinic Lung Cancer Cohort between 2004 and 2008, alcohol consumption (within 6 mo of diagnosis) was as follows: 199 (49%) used none, 158 (14%) were moderate users (7 drinks per wk or less), and 47 (12%) were heavier consumers (more than 7 drinks per wk). Only heavier consumers had a lower likelihood of anorexia (odds ratio: 0.49; 95% CI: 0.25, 0.94; P = 0.03) and weight loss (odds ratio: 0.43; 95% CI: 0.20, 0.91; P = 0.03) compared to those who consumed no alcohol. These conclusions were sustained in multivariate analyses. Neither moderate nor heavier consumption was associated with better or worse survival, although, in univariate analyses, a drop in alcohol consumption was associated with worse survival. This report suggests a need for further study of alcohol as a palliative agent for cancer-associated loss of appetite and weight.

Entities:  

Mesh:

Year:  2011        PMID: 21999412     DOI: 10.1080/01635581.2011.607543

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  2 in total

1.  Maximizing quality of life remains an ultimate goal in the era of precision medicine: exemplified by lung cancer.

Authors:  Ping Yang
Journal:  Precis Clin Med       Date:  2019-03-11

2.  Metformin use and young age lung cancer: A case series report.

Authors:  B O Deng; Y I Wang; Dong Xie; Shawn M Stoddard; Ping Yang
Journal:  Oncol Lett       Date:  2016-03-08       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.